Limb-Girdle Muscular Dystrophy Type 2H Associated with Mutation in TRIM32, a Putative E3-Ubiquitin–Ligase Gene
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index; 11 of the 44 sources its claims cite were checked for support.
Abstract
Limb-girdle muscular dystrophy type 2H (LGMD2H) is a mild autosomal recessive myopathy that was first described in the Manitoba Hutterite population. Previous studies in our laboratory mapped the causative gene for this disease to a 6.5-Mb region in chromosomal region 9q31-33, flanked by D9S302 and D9S1850. We have now used additional families and a panel of 26 microsatellite markers to construct haplotypes. Twelve recombination events that reduced the size of the candidate region to 560 kb were identified or inferred. This region is flanked by D9S1126 and D9S737 and contains at least four genes. Exons of these genes were sequenced in one affected individual, and four sequence variations were identified. The families included in our study and 100 control individuals were tested for these variations. On the basis of our results, the mutation in the tripartite-motif-containing gene (TRIM32) that replaces aspartate with asparagine at position 487 appears to be the causative mutation of LGMD2H. All affected individuals were found to be homozygous for D487N, and this mutation was not found in any of the controls. This mutation occurs in an NHL (named after the proteins NCL1, HT2A, and LIN-41) domain at a position that is highly conserved. NHL domains are known to be involved in protein-protein interactions. Although the function of TRIM32 is unknown, current knowledge of the domain structure of this protein suggests that it may be an E3-ubiquitin ligase. If proven, this represents a new pathogenic mechanism leading to muscular dystrophy.
Overview
CoChat Summary
## TL;DR
The paper fine-maps the autosomal recessive LGMD2H locus in Manitoba Hutterite families from a 6.5 Mb interval to 560 kb and identifies TRIM32 D487N as the most likely disease-causing mutation. The authors propose that TRIM32 may function as an E3 ubiquitin ligase, suggesting a novel ubiquitin-proteasome mechanism for muscular dystrophy.
## Key findings
- Haplotype analysis in six interrelated Hutterite families identified 12 recombination events that reduced the LGMD2H candidate region from 6.5 Mb to 560 kb, flanked by D9S1126 and D9S737.
- Sequencing of the genes in this interval found four sequence variations; the best candidate was TRIM32 c.1459G>A (p.D487N).
- The paper reports that all 35 affected individuals with LGMD2H were homozygous for V4(Asn)/D487N, and the mutation was not observed in 100 controls.
- The altered residue lies in the third NHL domain of TRIM32 and is one of the two most highly conserved positions in that domain; the authors also state that TRIM32 shows two transcript sizes, 3.3 and 2.5 kb, and is expressed in skeletal muscle.
## Methods
- Studied 35 clinically affected Hutterite patients and their immediate families; genotypes were obtained for 117 individuals across six interrelated families, with 100 controls used for comparison.
- Performed haplotype analysis using 22 additional microsatellite markers to refine the disease interval, then used SSCA, DNA sequencing, and PCR/restriction assays to screen candidate genes and sequence variants.
- Assessed TRIM32 expression with a 12-tissue northern blot and used RT-PCR on RNA from cultured skin fibroblasts to examine whether the PAPPA silent variant affected splicing.
## Limitations
- The paper explicitly notes that the information they possessed did not exclude the possibility that V3 may contribute additional effects to the phenotype.
- They also state that they cannot exclude the possibility that V3 affects an exonic splicing enhancer active only in muscle or mRNA secondary structure; this is a stated uncertainty.
- Evident from the text: the causal claim is based on genetic segregation, absence in controls, and domain conservation, but the paper does not provide functional proof that TRIM32 D487N alters ubiquitin-ligase activity.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 4 Not valid · 19 Not checked · 55 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“TRIM32 has, from N- to C-terminal ends, a RINGfinger domain, a B1 box, a coiled-coil domain, and six NHLdomains”
What the sources say
- Could not verifycites Apweiler et al. 2001 sourceExperimental — accuracy not yet measured
The Integration Methods section (p. 2) explains how InterPro describes domains in multidomain proteins, but it does not describe TRIM32. Searches for TRIM32, RING finger, B1 box, coiled-coil, and NHL domains found no passage establishing the claimed domains, their order, or the count of six. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The V3(T) allele was found to have a frequency of 2% in controls.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Three recombination events were identified in individuals C-06, C-07, and E-11, thereby reducing the candidate region from 6.5 Mb to an interval of 713 kb flanked by D9S241 and D9S931 (fig. 1).”
plainstates a causen = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All affected individuals were found to be homozygous for D487N, and this mutation was not found in any of the controls.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SSCA of exons located between the flanking microsatellitemarkers D9S1126 and D9S737 revealed only one silent substitution (i.e., V3) in PAPPA.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
26 more claims
Create a free account to see all 86 claims and every source verdict.
- Probably not a substantial claim. 40
- It may state two separate claims as one. 25
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Subjects and Methods
“Table 1 Four Sequence Variations Found in Exons within the LGMD2H Candidate Region”
§ Mutation Screening
“V1, an 11-bp deletion in intron 2 of PAPPA, can be excluded as the disease-causing mutation, because it does not segregate with LGMD2H and is outside the candidate region as defined by an inferred ancestral recombination event (in individual E-23; fig. 2).”
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · cited 1×
“Parkin, the product of PARK2, is known to be a RINGfinger–containing E3-Ub ligase (Shimura et al. 2000).”
BackgroundThe tripartite motif family identifies cell compartments
Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S., Cainarca, S., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2140 · Cited by 1,366 · cited 3×
“It was originally discovered using a yeast two-hybrid assay with the human immunodeficiency virus type 1 Tat acting as bait (Fridell et al. 1995; Reymond et al. 2001).”
BackgroundMethodJoazeiro, C. A. P., & Weissman, A. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00077-5 · Cited by 1,249 · cited 2×
“It has been shown that the RINGfinger domain of an E3 ligase mediates interaction with the E2-conjugating enzyme and is the source of the ligase activity (Joazeiro and Weissman 2000).”
BackgroundApweiler, R. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.37 · Cited by 1,079
Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S., & Selkoe, D. J. (2001) · Science · doi:10.1126/science.1060627 · Cited by 1,053
Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., & Takahashi, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00407-x · Cited by 1,050
Recommendations for a nomenclature system for human gene mutations
Antonarakis, S. E., & Nomenclature Working Group (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:1<1::aid-humu1>3.0.co;2-o · Cited by 943
Slack, F. J., Basson, M., Liu, Z., Ambros, V., Horvitz, H. R., & Ruvkun, G. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80245-2 · Cited by 751
Cited by
Items 201–261 of 261
Distrofias musculares de cinturas autosómicas recesivas
Hernández-Caballero, M. E., Miranda‐Duarte, A., Cedillo, R. E. E., & Villegas-Castrejón, H. (2010) · Revista de Neurología · doi:10.33588/rn.5108.2010376 · Cited by 4
Limb-girdle muscular dystrophy
Liang, W., & Nishino, I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00028-5 · Cited by 3
Case report: A novel patient presenting TRIM32-related limb-girdle muscular dystrophy
Rimoldi, M., Romagnoli, G., Magri, F., Antognozzi, S., Cinnante, C. M., Saccani, E., Ciscato, P., Zanotti, S., Velardo, D., Corti, S. P., et al. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2023.1281953 · Cited by 3
Özkan, S., Sanhal, C. Y., Yeniel, Ö., et al. (2015) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2015.08.005 · Cited by 2
Molecular variants of Bardet-Biedl Syndrome
Iqbal, H., Wahedi, H. M., Hafeez, F. Y., & Mir, A. (2010) · Journal of Cell Biology and Genetics · doi:10.5897/jcbg.9000002 · Cited by 3
MUSCULAR DYSTROPHIES PROTEINS EVALUATION BY WESTERN BLOTT AND IMMUNOFLUORESCENCE
Gaina, G. F., Manole, E., Matanie, C., et al. (2008) · Cited by 2
Description of muscle disease – specific diseases
Karpati, G. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511674747.014 · Cited by 2
MOLECULAR GENETICS OF TIBIAL MUSCULAR DYSTROPHY (TMD) AND A NOVEL DISTAL MYOPATHY
Haravuori, H. (2003) · Työväentutkimus Vuosikirja · Cited by 2
Inhibition of coronaviral exonuclease activity by TRIM-mediated SUMOylationPreprint
Balakrishnan, K., Chakraborty, S., Chiang, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.28.667286 · Cited by 2
Xiong, L., Lazzari, E., Pacor, S., Monego, S. D., Piovesan, E., Licastro, D., & Meroni, G. (2026) · FEBS Journal · doi:10.1111/febs.70619 · Cited by 2
Limb girdle muscular dystrophies: The clinicopathological viewpoint
Urtizberea, J., & Leturcq, F. (2007) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.37813 · Cited by 1
Limb-Girdle Muscular Dystrophy Type 2H
Angelini, C. I. (2017) · Springer eBooks · doi:10.1007/978-3-319-56454-8_17 · Cited by 1
Autosomal Recessive Limb-Girdle Muscular Dystrophies
Tanboon, J., & Nishino, I. (2023) · Current clinical neurology · doi:10.1007/978-3-031-44009-0_6 · Cited by 1
Lim, L. E., Thornton, C. A., & Rando, T. A. (2007) · Elsevier eBooks · doi:10.1016/b978-012088592-3/50086-4 · Cited by 2
Sakthivel, M. S. M. (2013) · Shodhganga · Cited by 1
Distrofia muscular de cinturas em crianças: caracterização clínica, histológia e molecular
de Albuquerque, M. A. V. (2013) · doi:10.11606/t.5.2013.tde-03012014-154533 · Cited by 1
Limb Girdle Muscular Dystrophies
Norwood, F., Visser, M., Eymard, B., et al. (2006) · doi:10.1002/9780470753279.ch26 · Cited by 1
Biochemical and Cell Biological Studies of TRIM37 Defective in Mulibrey Nanism
Kallijärvi, J. (2006) · Työväentutkimus Vuosikirja
Development of the zebrafish as a model for Bardet-Biedl syndrome
Yen, H.-J. (2007) · doi:10.17077/etd.sadjwdsv · Cited by 1
“The TRIM32 gene encodes an E3 ubiquitin ligase and it has been reported previously as the disease gene for the limb-girdle muscular dystrophy type 2H (LGMD2H), a mild autosomal recessive myopathy that was first discovered in the Manitoba Hutterite population (Frosk et al., 2002).”
BackgroundInfluentialChiang, A. P.-F. (2006) · doi:10.17077/etd.v3b1w8k9
“associated with autosomal recessive LGMD (Frosk et al. 2002).”
BackgroundInfluentialElucidating a role for BBS3 in syndromic and non-syndromic retinal disease
Pretorius, P. R. (2010) · doi:10.17077/etd.ie8eapd4
“A point mutation (D487N) in the highly conserved C-terminal NHL domain is responsible for the muscular dystrophy phenotype (Frosk et al. 2002).”
Patho-genetic characterization of the muscular dystrophy gene myotilin
Garvey, S. M. (2007) · DukeSpace (Duke University)
Proteins of Autophagy: LAMP‐2, VMA21, VCP, and TRIM32
Malicdan, M. C. V., & Nishino, I. (2013) · Wiley eBooks · doi:10.1002/9781118635469.ch25
Zhu, R., Liu, X., & He, Z. (2013) · Neurological Research · doi:10.1179/1743132813y.0000000270
Neuromuscular disorders associated with cerebral malformations
Mah, J. K. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)87022-9
P4 Pathophysiology of anoctaminopathy (LGMD2L)
Kirk, C., Lochmüller, H., Bushby, K. M. D., & Laval, S. H. (2014) · Neuromuscular Disorders · doi:10.1016/s0960-8966(14)70020-3
Yu, C.-Y., Wang, B., Wang, Z., Cao, Z., Li, J., & Xiao, X. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.08.556
Macaulay, S. (2007) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Molecular diagnosis of muscular dystrophies, focused on limb girdle muscular dystrophies
Fernández-Balbuena, C. N., & Teijeira, S. (2009) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530050903313988
Li, Z., Parlakian, A., Gao-Li, J., Mericskay, M., & Agbulut, O. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2904-7_11 · Cited by 1
Darras, B. T., & Jones, H. R. (2006) · Elsevier eBooks · doi:10.1016/b978-0-7506-7251-1.50042-3
Molecular and Pathological Diagnosis of Muscular Dystrophies
Choi, Y. (2006) · Hanyang Medical Reviews
The Role of BERP in Mammalian Systems
Cheung, C. C.-S. (2009) · TSpace (University of Toronto)
Role of EMG1 in Bowen-Conradi syndrome and in ribosome biogenesis
Armistead, D. J. (2009) · Mspace (University of Manitoba)
Limb girdle muscular dystrophy in the Hutterite population of North America
Frosk, P. (2005) · Mspace (University of Manitoba)
Self-citationvan der Graaf, K., & White‐Cooper, H. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/543942
Molecular genetic and epigenetic analysis of osteoarthritis
Rogers, E. L. (2017)
Carias, K. V. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-fe86-e477
Aplicación de técnicas de proteómica para el estudio de enfermedades neuromusculares
Gómez, T., & de la, C. (2012) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 1
Limb Girdle Muscular Dystrophies
Norwood, F., Visser, M., Eymard, B., et al. (2010) · doi:10.1002/9781444328394.ch23
Chhetri, S. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7435 · Cited by 1
Limb-girdle muscular dystrophy
Liang, W., & Nishino, I. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813866-3.00025-4
Fast recontruction of compact context-specific network modelsPreprint
Pacheco, M. P. (2018) · Thesis Commons (OSF Preprints) · doi:10.31237/osf.io/8xcwa
Baydan, F., Tiftikçioğlu, B. İ., & Dınız, G. (2023) · Springer eBooks · doi:10.1007/978-3-031-33924-0_12 · Cited by 1
Llansó, L., Ravenscroft, G., Aceituno, C., et al. (2024) · medRxiv · doi:10.1101/2024.05.14.24307284
(2000) · Time to knit · doi:10.1016/s0246-0378(19)30009-0
TRIM32 controls timely cell cycle exit in muscular differentiation through c-Myc down-regulationPreprint
Xiong, L., Lazzari, E., Pacor, S., Monego, S. D., Piovesan, E., Licastro, D., & Meroni, G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.25.661523
“LGMDR8 pathogenesis is not totally unraveled and reported findings support a role for TRIM32 in both muscle atrophy and regeneration.”
InfluentialTlili, A., & Mutery, A. A. (2025) · Human Genomics · doi:10.1186/s40246-025-00809-7
Jewett, G., Luk, C., Osman, H., & Pfeffer, G. (2025) · Journal of Neuromuscular Diseases · doi:10.1177/22143602251389759
“72 Most relevant to neuromuscular specialists is the high prevalence of limb girdle muscular dystrophy, 73 which has been linked to pathogenic founder variants in TRIM32 74 and FKRP .”
Ageing of neural stem cells in a Parkinson's disease Model
Menzl, I. (2013) · University of Vienna · doi:10.25365/thesis.27046
Role of the post-transcriptional regulators Pumilio1 and Pumilio2 in murine hematopoietic stem cells
Michelet, F. (2013) · theses.fr (ABES) · doi:10.70675/18f333eaz6d70z4c79za7e7z74e7b2301434
“vessels in the bone marrow (23) (24) (25).”
Butchbach, M. E. R., Kale, J., Simeone, S. D., Chen, J. Y., Anderson, R. L., Prichina, A. Y., del Gaudio, D., Stabley, D. L., Holbrook, J., Culcea, E., et al. (2026) · Genetics in Medicine · doi:10.1016/j.gim.2026.102535
Régulation de la stabilité de la protéine anti-apoptotique BCL2A1
Lionnard, L. (2018) · theses.fr (ABES) · doi:10.70675/1eec02ffz98dez4a56z98e2z389a2cd8558d
Bioinformatics tools for the systems biology of dysferlin deficiency
Malatras, A. (2017) · theses.fr (ABES) · doi:10.70675/8817b812z4587z474bzae68ze8e5dfc7ade1 · Cited by 1
Identification of new levers to fight muscle atrophy : benefit of the hibernating brown bear model
Cussonneau, L. (2022) · theses.fr (ABES) · doi:10.70675/1a11a81bzf829z4ba2zba9az6f3f4841c773
Limb Girdle Muscular Dystrophy Associated With TRIM32 Variants: A National Cohort Study
Guérémy, A., Morel, V., Stojkovic, T., Bouhour, F., Nadaj‐Pakleza, A., Nectoux, J., Fortanier, É., Magot, A., Sacconi, S., Eymard, B., et al. (2026) · Muscle & Nerve · doi:10.1002/mus.70229
TRIM28 and TRIM32: multifaceted regulators of innate immunity and antiviral defence
Biju, S. S., Arya, R. P., & Lahon, A. (2026) · Immunologic Research · doi:10.1007/s12026-026-09799-7 · Cited by 1
“…coiled-coil domains are causally involved in the pathogenesis of Limb-Girdle Muscular Dystrophy Type 2 H (LGMD2H) and Sarcotubular Myopathy (STM), which both present with proximal muscle weakness, although other clinical findings, such as facial, axial or distal weakness, can be associated [92 ].”
TRIM32-mediated ubiquitination of STING promotes glycolysis and tumor progression
Zhou, H., Guan, Z., Yin, Z., Shan, B., Wu, J., Lu, K., Li, J., Zhang, H., 王剑云, Liu, C., et al. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01855-x
Chronological patterns of pathogenic variant distributions in muscular dystrophy genes
Stenger, T. D., Bruels, C. C., & Kang, P. B. (2026) · Neuromuscular Disorders · doi:10.1016/j.nmd.2026.107424
Metadata
- Authors
- Frosk, P., Weiler, T., Nylen, E., Sudha, T., Greenberg, C. R., Morgan, K., Fujiwara, T. M., & Wrogemann, K.
- Affiliations
- University of Manitoba (CA)
- Research Institute of the McGill University Health Centre (CA)
- Corresponding author
- Wrogemann, Klaus
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 70
- Issue
- 3
- Pages
- 663-672
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC447621
- OpenAlex
- W2024140773
- Semantic Scholar
- 2761196aa5154b43901a405f8b3d734bf576cfe7
- Cited by
- 261
- References
- 34
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 8 · 2020: 13 · 2019: 12 · 2018: 5 · 2017: 7 · 2016: 9 · 2015: 9 · 2014: 18 · 2013: 16 · 2012: 17
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4158 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- TRIM32, E3 ubiquitin ligase, autosomal recessive myopathy, haplotype mapping, candidate gene mapping, protein-protein interaction
- MeSH terms
- Tripartite Motif Proteins, Amino Acid Sequence, Animals, DNA Mutational Analysis, Ethnicity, Exons, Female, Genetic Testing, Haplotypes, Homozygote, Humans, Ligases, Male, Manitoba, Molecular Sequence Data, Muscular Dystrophies, Mutation, Pedigree, RNA, Messenger, Transcription Factors, Consensus Sequence, Sequence Alignment, Protein Structure, Tertiary, Ubiquitin-Protein Ligases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.